What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Internal medicine, Neuroendocrine tumors, Pathology, Cancer research and Oncology are his primary areas of study.
His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Surgery.
His studies in Neuroendocrine tumors integrate themes in fields like Clinical trial, Carcinoid tumors, Everolimus, Sunitinib and Octreotide.
The Pathology study combines topics in areas such as Colorectal cancer, Gastrointestinal tract and Endocrine system.
His studies deal with areas such as Exome sequencing, Exome, Immunohistochemistry, Germline mutation and DNA repair as well as Cancer research.
His Oncology study combines topics from a wide range of disciplines, such as Adrenal gland and Metastasis.
His most cited work include:
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors (1042 citations)
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. (553 citations)
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial (537 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Neuroendocrine tumors, Oncology, Gastroenterology and In patient.
As part of one scientific family, he deals mainly with the area of Internal medicine, narrowing it down to issues related to the Surgery, and often Clinical trial.
His biological study spans a wide range of topics, including Sunitinib, Octreotide, Cancer research and Everolimus.
He combines subjects such as Lung and Sirolimus with his study of Everolimus.
His work in Oncology covers topics such as Chemotherapy which are related to areas like Irinotecan.
His Gastroenterology research incorporates elements of Neutropenia, Confidence interval and Adenocarcinoma.
He most often published in these fields:
- Internal medicine (69.05%)
- Neuroendocrine tumors (51.85%)
- Oncology (37.04%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (69.05%)
- Neuroendocrine tumors (51.85%)
- Oncology (37.04%)
In recent papers he was focusing on the following fields of study:
Matthew H. Kulke focuses on Internal medicine, Neuroendocrine tumors, Oncology, In patient and Gastroenterology.
Carcinoid syndrome, Everolimus, Quality of life, Progression-free survival and Hazard ratio are the core of his Internal medicine study.
His Progression-free survival research includes themes of Survival analysis and Phases of clinical research.
Matthew H. Kulke has researched Neuroendocrine tumors in several fields, including Cancer, Clinical endpoint, Adverse effect and Octreotide.
His Oncology research integrates issues from Treatment outcome, Rectum and Cohort.
His research in Colorectal cancer focuses on subjects like Microsatellite instability, which are connected to Cancer research.
Between 2016 and 2021, his most popular works were:
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors (1042 citations)
- Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. (164 citations)
- Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome. (150 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Matthew H. Kulke mainly focuses on Internal medicine, Neuroendocrine tumors, Oncology, Gastroenterology and Clinical endpoint.
His Internal medicine research incorporates themes from Endocrinology and Surgery.
His study in Neuroendocrine tumors is interdisciplinary in nature, drawing from both Progressive disease, Clinical trial, Phases of clinical research and Octreotide.
His Oncology study combines topics in areas such as Adrenal gland, Pathology, Gastrointestinal tract, Distant metastasis and Advanced disease.
His research in Pathology tackles topics such as Small intestine which are related to areas like Cancer research.
His research ties Carcinoma and Gastroenterology together.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
